Rock Springs Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Hold |
|
|||||
|
2025
Q1 | $1.31M | Buy |
|
|||||
|
2024
Q4 | $4.91M | Buy |
|
|||||
|
2024
Q3 | $5.76M | Hold |
|
|||||
|
2024
Q2 | $6.12M | Hold |
|
|||||
|
2024
Q1 | $13.6M | Hold |
|
|||||
|
2023
Q4 | $7.07M | Sell |
|
|||||
|
2023
Q3 | $4.32M | Hold |
|
|||||
|
2023
Q2 | $11.2M | Sell |
|
|||||
|
2023
Q1 | $16.9M | Hold |
|
|||||
|
2022
Q4 | $24M | Buy |
|
|||||
|
2022
Q3 | $27.6M | Hold |
|
|||||
|
2022
Q2 | $18.8M | Buy |
|
|||||
|
2022
Q1 | $15M | Buy |
|
|||||
|
2021
Q4 | $20.2M | Buy |
|
|||||
|
2021
Q3 | $28.5M | Buy |
|
|||||
|
2021
Q2 | $38.6M | Buy |
|
|||||
|
2021
Q1 | $44.9M | Buy |
|
|||||
|
2020
Q4 | $54.9M | Buy |
|
|||||
|
2020
Q3 | $35.1M | Buy |
|
|||||
|
2020
Q2 | $44M | Buy |
|
|||||
|
2020
Q1 | $7.19M | Hold |
|
|||||
|
2019
Q4 | $7.07M | Sell |
|
|||||
|
2019
Q3 | $2.21M | Hold |
|
|||||
|
2019
Q2 | $5.67M | Hold |
|
|||||
|
2019
Q1 | $7.36M | Buy |
|
|||||
|
2018
Q4 | $4.08M | Hold |
|
|||||
|
2018
Q3 | $10M | Hold |
|
|||||
|
2018
Q2 | $17.9M | Sell |
|
|||||
|
2018
Q1 | $20.5M | Sell |
|
|||||
|
2017
Q4 | $21.8M | Sell |
|
|||||
|
2017
Q3 | $23M | Sell |
|
|||||
|
2017
Q2 | $21.3M | Buy |
|